Summary of population characteristics and outcomes by site, sex and time period based on EPR data
| Intervention site | Control site | |||
| Pre | Post | Pre | Post | |
| Males | ||||
| Total attendances, n | 17 626 | 16 787 | 11 920 | 12 085 |
| Total episodes of care, n | 11 445 | 10 628 | 7946 | 8021 |
| Total patients, n | 9932 | 9151 | 6271 | 6335 |
| Symptomatic attendances, n (%) | 7307 (41.5%) | 7084 (42.2%) | 4735 (39.7%) | 4556 (37.7%) |
| Complex attendances, n (%) | 9869 (56.0%) | 9259 (55.2)% | 4458 (37.4%) | 4940 (40.9%) |
| Ethnic minority attendances, n (%) | 2834 (16.1%) | 3025 (18.0%) | 7244 (60.8%) | 7311 (60.5%) |
| MSM attendances, n(%) | 5300 (30.1%) | 5418 (32.3%) | 2529 (21.2%) | 2849 (23.6%) |
| Mean age, years | 30.2 | 30.8 | 34.9 | 35.1 |
| Urethral GC swabs per consultation | 0.18 | 0.11 | 0.08 | 0.07 |
| Median time-to-notification | 10.90 | 6.73 | 4.51 | 4.95 |
| Examinations per symptomatic attendance | 0.76 | 0.67 | 0.64 | 0.60 |
| Follow-up attendances per episode | 0.40 | 0.36 | 0.50 | 0.37 |
| Females | ||||
| Total attendances | 28 487 | 20 289 | 20 931 | 16 910 |
| Total episodes of care | 18 616 | 13 866 | 13 971 | 11 660 |
| Total patients | 16 779 | 12 794 | 11 799 | 9902 |
| Symptomatic attendances | 6312 (22.2%) | 4929 (24.3%) | 6860 (32.8%) | 5561 (32.9%) |
| Complex attendances | 26 022 (91.3%) | 18 173 (89.6%) | 12 328 (58.9%) | 11 221 (66.4%) |
| Ethnic minority attendances | 3979 (14.0%) | 3067 (15.1%) | 12 647 (60.4%) | 10 107 (59.8%) |
| Mean age | 25.1 | 25.8 | 29.8 | 30.4 |
| Cervical GC swabs per consultation | 0.20 | 0.04 | 0.03 | 0.03 |
| Median time-to-notification (median, IQR) | 10.58 | 3.52 | 4.90 | 5.32 |
| Examinations per symptomatic attendance | 0.73 | 0.70 | 0.58 | 0.60 |
| Follow-up attendances per episode | 0.36 | 0.34 | 0.31 | 0.23 |
EPR, electronic patient record; GC, gonorrhoea culture; MSM, men who have sex with men.